Zymergen vs Gingko Bioworks, A Tale of Two Synthetic Biology companies
goodai.substack.com
A little more than three months after pricing its IPO at the top of its expected range and soaring out of the gate, Zymergen is warning investors that revenue from its experimental products won’t be coming anytime soon. The company also said that Josh Hoffman
Zymergen vs Gingko Bioworks, A Tale of Two Synthetic Biology companies
Zymergen vs Gingko Bioworks, A Tale of Two…
Zymergen vs Gingko Bioworks, A Tale of Two Synthetic Biology companies
A little more than three months after pricing its IPO at the top of its expected range and soaring out of the gate, Zymergen is warning investors that revenue from its experimental products won’t be coming anytime soon. The company also said that Josh Hoffman